f Solitary Lung Nodule: To Ablate or not to Ablate?

References

1. BrayF. LaversanneM. SungH. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202474322926310.3322/caac.21700
   [Google Scholar]
2. CruickshankA. StielerG. AmeerF. Evaluation of the solitary pulmonary nodule.Intern. Med. J.201949330631510.1111/imj.14163
   [Google Scholar]
3. HowladerN. ForjazG. MooradianM.J. The effect of advances in lung-cancer treatment on population mortality.N. Engl. J. Med.2020383764064910.1056/NEJMoa1916623
   [Google Scholar]
4. GouldM.K. TangT. LiuI.L.A. Recent trends in the identification of incidental pulmonary nodules.Am. J. Respir. Crit. Care Med.2015192101208121410.1164/rccm.201505‑0990OC
   [Google Scholar]
5. MazzoneP.J. LamL. Evaluating the patient with a pulmonary nodule.JAMA2022327326410.1001/jama.2021.24133
   [Google Scholar]
6. PatelP.P. DuongD.K. MahajanA.K. ImaiT.A. Single-setting robotic lung nodule diagnosis and resection.Thorac. Surg. Clin.202333323324410.1016/j.thorsurg.2023.03.001
   [Google Scholar]
7. QuirkM.T. LeeS. MuraliN. GenshaftS. AbtinF. SuhR. Alternatives to surgery for early-stage non-small cell lung cancer.Clin. Chest Med.202041219721010.1016/j.ccm.2020.02.002
   [Google Scholar]
8. LencioniR. CrocettiL. CioniR. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).Lancet Oncol.20089762162810.1016/S1470‑2045(08)70164‑5
   [Google Scholar]
9. MacchiM. BelfioreM.P. FloridiC. Radiofrequency versus microwave ablation for treatment of lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial.Med. Oncol.20173459610.1007/s12032‑017‑0964‑y
   [Google Scholar]
10. YangX. JinY. LinZ. Microwave ablation for the treatment of peripheral ground-glass nodule-like lung cancer: Long-term results from a multi-center study.J. Cancer Res. Ther.20231941001101010.4103/jcrt.jcrt_967_23
    [Google Scholar]
11. SharmaA. AbtinF. ShepardJ.A.O. Image-guided ablative therapies for lung cancer.Radiol. Clin. North Am.201250597599910.1016/j.rcl.2012.06.001
    [Google Scholar]
12. ZemlyakA. MooreW.H. BilfingerT.V. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer.J. Am. Coll. Surg.20102111687210.1016/j.jamcollsurg.2010.02.050
    [Google Scholar]
13. TadaA. HirakiT. IguchiT. Influence of radiofrequency ablation of lung cancer on pulmonary function.Cardiovasc. Intervent. Radiol.201235486086710.1007/s00270‑011‑0305‑6
    [Google Scholar]
14. DupuyD.E. FernandoH.C. HillmanS. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.Cancer2015121193491349810.1002/cncr.29416
    [Google Scholar]